However, we were not able to detect any differences in circulating markers of oxidative stress between the two groups of ARDS patients, but total antioxidant status and ceruloplasmin (a copper-containing ferroxidase) were reduced in COVID-19. The gene discussed is CP; the disease is COVID-19.